Search results

Help

Rocuronium (category Neuromuscular blockers)
Butterworth IV, John F.; Mackey, David C.; Wasnick, John D. (2022), "Neuromuscular Blocking Agents", Morgan & Mikhail’s Clinical Anesthesiology (7 ed.), New

2 KB (86 words) - 14:27, 22 December 2022
Vecuronium (category Neuromuscular blockers)
clinical practice Lien, Cynthia A.; Eikermann, Matthias (2013), "Neuromuscular Blockers and Reversal Drugs", Pharmacology and Physiology for Anesthesia

5 KB (420 words) - 09:10, 5 January 2023
Succinylcholine (category Neuromuscular blockers)
Succinylcholine, also known as suxamethonium, is a short-acting neuromuscular blocker used during intubation. hyperkalemia increased risk of malignant

2 KB (25 words) - 16:41, 17 July 2022
Mivacurium (category Neuromuscular blockers)
in the United States of America Goodwin, G., Joseph, V. (2015). Neuromuscular Blockers. In: Kaye, A., Kaye, A., Urman, R. (eds) Essentials of Pharmacology

6 KB (503 words) - 09:28, 5 January 2023
Cisatracurium (category Neuromuscular blockers)
retrieved 2023-01-05 Lien, Cynthia A.; Eikermann, Matthias (2013), "Neuromuscular Blockers and Reversal Drugs", Pharmacology and Physiology for Anesthesia

5 KB (449 words) - 14:14, 8 January 2023
Table of contents (section Neuromuscular blockers)
Brachial plexus blocks Interscalene block Supraclavicular block Infraclavicular block Axillary block Digital block Wrist block Intercostal nerve block Pectoralis

48 KB (3,882 words) - 14:34, 16 August 2023
Myasthenia gravis (section Neuromuscular blockade)
to nondepolarizing neuromuscular blockers Resistant to succinylcholine At increased risk for developing phase II neuromuscular block, particularly with

6 KB (544 words) - 04:57, 17 July 2022
Amyotrophic lateral sclerosis
disease may incite hyperkalemia after administration Non-depolarizing neuromuscular blockers may be prolonged Take caution with regional anesthesia, although

3 KB (171 words) - 05:51, 14 June 2023
Pharmacogenetics and pharmacogenomics (section Neuromuscular blockers)
In those patients who are heterozygous for Asp70Gly, the effects of neuromuscular blockade may be prolonged three to eight times that of normal3. In those

18 KB (2,664 words) - 19:49, 4 October 2022
Sugammadex (category Neuromuscular blocker reversal agents)
Sugammadex Sugammadex is used to reverse neuromuscular blockade from rocuronium and vecuronium. If a patient requires reparaylsis after administration

3 KB (161 words) - 00:34, 30 March 2022
Antibiotics
reaction, not anaphylaxis Allergic reactions are more likely from neuromuscular blockers than antibiotics From Vaisman, et al. JAMA 2017 Patients at increased

10 KB (1,348 words) - 11:29, 1 September 2023
Vagus nerve stimulation
preferred for rapid emergence to facilitate early neuro exam. Patient neuromuscularly blocked throughout to reduce risk of inadvertent injury. No neuromonitoring

4 KB (82 words) - 17:59, 31 July 2022
Neuromuscular blockade
Neuromuscular blockade involves the use of neuromuscular blocking agents (NMBAs) (i.e. paralytics) to facilitate endotracheal intubation and/or surgical

8 KB (1,025 words) - 04:45, 4 July 2022
Atracurium
Clinical data Drug class Neuromuscular blocker Routes of administration Intravenous Dosage Pharmacodynamics Mechanism of action Nicotinic acetylcholine

1 KB (9 words) - 00:32, 30 March 2022
Pancuronium
Clinical data Drug class Neuromuscular blocker Dosage Pharmacodynamics Mechanism of action Nicotinic acetylcholine antagonism Pharmacokinetics Physical

1 KB (9 words) - 00:33, 30 March 2022
Liver transplant
(low albumin level), and increased sensitivity. Non depolarizing neuromuscular blocking agents should be chosen with patients organ function in mind. Often

24 KB (969 words) - 22:28, 14 January 2024
Atropine
for reversal of neuromuscular blockade in order to reduce their muscarinic effects. Treatment of bradycardia (vasovagal response, AV block, bradyarrhythmias)

6 KB (510 words) - 18:18, 10 January 2024

Search results Help

Search results

Help